Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13494)

• Formulation Name: Methotrexate 5 mg tablet
• Company: Teva Women's Health

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methotrexate	(DM2TEOL)	leukaemia	2A60-2B33	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
FD&C blue no. 1	(E00263)	19700	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Quinoline yellow WS	(E00309)	24671	Colorant
Sodium carbonate monohydrate	(E00454)	2735133	Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent